You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasmodioum falciparum 014

Showing 1 - 25 of 491
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vaccine Reaction Trial in Silver Spring (FMP014, ALFQ)

Recruiting
  • Vaccine Reaction
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research
Apr 14, 2021

Malaria Trial (BNT165e, Placebo)

Not yet recruiting
  • Malaria
  • BNT165e
  • Placebo
  • (no location specified)
Sep 29, 2023

Malaria Trial (Meplazumab for Injection)

Not yet recruiting
  • Malaria
  • Meplazumab for Injection
  • (no location specified)
Sep 13, 2023

Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal

Recruiting
  • Covid19
  • Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
  • +4 more
  • Lenexa, Kansas
  • +1 more
Aug 1, 2022

Ulcerative Colitis Trial in Linköping, Stockholm, Uppsala (BGP-014, Placebo)

Recruiting
  • Ulcerative Colitis
  • BGP-014
  • Placebo
  • Linköping, Sweden
  • +3 more
Aug 22, 2022

Coronary Restenosis Trial in Hasselt, Massy (SELUTION SLR™ DEB, Control)

Recruiting
  • Coronary Restenosis
  • SELUTION SLR™ DEB
  • Control
  • Hasselt, Belgium
  • +1 more
Nov 10, 2022

Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
Feb 17, 2023

Amyotrophic Lateral Sclerosis Trial in Worldwide (RT001, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Tartu, Estonia
  • +3 more
Apr 7, 2022

Non-alcoholic Steatohepatitis, Hepatic Impairment Trial (Efinopegdutide)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Hepatic Impairment
  • (no location specified)
Sep 18, 2023

Opioid Use Disorder, Moderate Trial in Berlin, New York (Levomethadone HCl, Methadone, Morphine Sulfate)

Recruiting
  • Opioid Use Disorder, Moderate
  • Levomethadone HCl
  • +4 more
  • Berlin, New Jersey
  • +1 more
Mar 16, 2022

Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities Trial (SELUTION SLR™ DEB

Not yet recruiting
  • Peripheral Arterial Disease
  • Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
  • SELUTION SLR™ DEB 014
  • Plain (Uncoated) Balloon Angioplasty (PTA)
  • (no location specified)
Apr 5, 2022

Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,

Recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
  • +7 more
Oct 7, 2023

Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)

Not yet recruiting
  • Malaria
  • Plasmodium Falciparum
  • P. falciparum infected erythrocytes
  • Bagamoyo, Tanzania
    Ifakara Health Institute
May 26, 2022

TES of Artemether-lumefantrine for Pf in Philippines in

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)

Not yet recruiting
  • Coronary Artery Disease
  • PCI with SELUTION SLR DCB
  • PCI with FDA approved "-limus" DES
  • Washington, District of Columbia
    MedStar Washington Hospital Center
Jul 7, 2023

Schizophrenia Trial in Garden Grove, Marlton (MK-8189, Placebo)

Active, not recruiting
  • Schizophrenia
  • Garden Grove, California
  • +2 more
Jan 31, 2023

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

Malaria,Falciparum, Malaria, Vivax, Malaria Trial in Manokwari (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Malaria,Falciparum
  • +5 more
  • Manokwari, West Papua, Indonesia
    Manokwari Regional General Hospital
Sep 11, 2023

Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5

Recruiting
  • Plasmodium Falciparum Malaria
  • artemether:lumefantrine (2.5 mg:30 mg)
  • Nanoro, Burkina Faso
  • +5 more
Nov 28, 2022

Critical Limb Ischemia, Peripheral Arterial Disease Trial in Worldwide (DCB, PTA)

Active, not recruiting
  • Critical Limb Ischemia
  • Peripheral Arterial Disease
  • DCB
  • PTA
  • Dendermonde, East-Flanders, Belgium
  • +9 more
Dec 21, 2021

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

TES of Artemether-lumefantrine for Pf in the Philippines in 2015

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)

Recruiting
  • Malaria
  • Plasmodium Falciparum
  • Pfs48/45 in Matrix-M
  • Oxford, United Kingdom
    CCVTM, University of Oxford
Dec 13, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

Active, not recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • VRC-MALMAB0100-00-AB (CIS43LS)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Sep 20, 2022

Acute Malaria Trial in Worldwide (M5717 330 mg, M5717 500 mg, M5717 660 mg)

Not yet recruiting
  • Acute Malaria
  • M5717 330 mg
  • +8 more
  • Nanoro, Burkina Faso
  • +4 more
Jan 9, 2023